Australia markets closed

Mereo BioPharma Group plc (MREO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.9800+0.0900 (+2.31%)
At close: 04:00PM EDT
4.0001 +0.02 (+0.51%)
Pre-market: 08:32AM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
57,421
68,182
127,265
31,984
-
Other short-term investments
-
-
-
-
0
Total cash
57,421
68,182
127,265
31,984
-
Other current assets
1,360
1,434
3,778
2,206
-
Total current assets
63,760
75,197
134,050
40,511
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
2,450
2,952
5,544
4,612
-
Accumulated depreciation
-800
-736
-2,130
-2,468
-
Net property, plant and equipment
1,650
2,216
3,415
2,144
-
Intangible assets
1,089
24,116
33,152
43,131
-
Total non-current assets
2,739
2,216
36,567
45,274
-
Total assets
66,499
77,413
170,617
85,786
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
13,326
-
-
19,850
Accounts payable
2,346
3,492
3,084
4,313
-
Accrued liabilities
3,461
3,573
5,164
5,694
-
Other current liabilities
30
1,355
1,713
-
354
Total current liabilities
9,486
24,375
16,926
11,673
-
Non-current liabilities
Long-term debt
4,394
-
19,413
21,999
7,045
Other long-term liabilities
764
182
107.971
84.4951
-
Total non-current liabilities
6,476
1,636
34,921
94,516
-
Total liabilities
15,962
26,011
51,846
106,189
-
Stockholders' equity
Common stock
2,775
2,478
2,369
1,386
-
Retained earnings
-419,630
-404,575
-400,799
-422,057
-
Accumulated other comprehensive income
-17,485
-21,687
184,759
181,562
-
Total stockholders' equity
50,537
51,402
118,771
-20,403
-
Total liabilities and stockholders' equity
66,499
77,413
170,617
85,786
-